The Association Between Buprenorphine/Naloxone and All-Cause Mortality in the United Kingdom (UK): An Interim Report

Oct-17

AUTHORS : Prof Marc Auriacombe, Centre Hospitalier Charles Perrens Pôle Addictologie – 121 rue de la Béchade – CS81285 – 33076 Bordeaux Cedex – Email: marc.auriacombe@u-bordeaux.fr – Profile: https://www.bordeaux-neurocampus.fr/en/staff/marc-auriacombe/ and also: https://iotodeducation.com/people/professor-marc-auriacombe/ – Cannot find details for Baher Mankabady (now works at Indivior), who would have been contact.

JOURNAL : Value in Health

REFERENCE: 20(9):A716

DOI : 10.1016/j.jval.2017.08.1907

The Association Between Buprenorphine/Naloxone and All-Cause Mortality in the United Kingdom (UK): An Interim Report

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study